Goldstream Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-500
| Closed | -$47.4K | – | 29 |
|
|
2024
Q1 | $47.4K | Hold |
500
| – | – | 0.03% | 26 |
|
|
2023
Q4 | $44.6K | Sell |
500
-1,700
| -77% | -$152K | 0.03% | 23 |
|
|
2023
Q3 | $161K | Hold |
2,200
| – | – | 0.13% | 35 |
|
|
2023
Q2 | $183K | Hold |
2,200
| – | – | 0.13% | 29 |
|
|
2023
Q1 | $168K | Sell |
2,200
-12,400
| -85% | -$945K | 0.18% | 27 |
|
|
2022
Q4 | $1.21M | Buy |
14,600
+5,600
| +62% | +$465K | 1.64% | 5 |
|
|
2022
Q3 | $714K | Sell |
9,000
-21,800
| -71% | -$1.73M | 0.55% | 6 |
|
|
2022
Q2 | $2.29M | Buy |
+30,800
| New | +$2.29M | 1.99% | 4 |
|